Clinical trial
Treatment of Endometriosis Pain With Rosiglitazone: A Prospective Phase 2 Clinical Trial
NCT00115661 is registered in ClinicalTrials.gov with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Endometriosis Pain With Rosiglitazone: A Prospective Phase 2 Clinical Trial
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2005
- Completion date
- May 31, 2006
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.